Evidence map›Paper›PMID 26240143›Full record

ArticleThe Journal of biological chemistry2015

Proteomic Analysis of GLUT4 Storage Vesicles Reveals Tumor Suppressor Candidate 5 (TUSC5) as a Novel Regulator of Insulin Action in Adipocytes.

Daniel J Fazakerley, Sheyda Naghiloo, Rima Chaudhuri, Françoise Koumanov, James G Burchfield, Kristen C Thomas, James R Krycer, Matthew J Prior, Ben L Parker, Beverley A Murrow and 4 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 63 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. GLUT4 On the move.The Biochemical journal · 2022
    Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Daniel J FazakerleyFrom the Charles Perkins Centre, School of Molecular Bioscience, and The Garvan Institute of Medical Research, Sydney, New South Wales 2010, Australia, and.
Sheyda NaghilooFrom the Charles Perkins Centre, School of Molecular Bioscience, and The Garvan Institute of Medical Research, Sydney, New South Wales 2010, Australia, and.
Rima ChaudhuriFrom the Charles Perkins Centre, School of Molecular Bioscience, and The Garvan Institute of Medical Research, Sydney, New South Wales 2010, Australia, and.
Françoise Koumanovthe Department of Biology and Biochemistry, University of Bath, Bath BA2 7AY, United Kingdom.
James G BurchfieldFrom the Charles Perkins Centre, School of Molecular Bioscience, and The Garvan Institute of Medical Research, Sydney, New South Wales 2010, Australia, and.
Kristen C ThomasFrom the Charles Perkins Centre, School of Molecular Bioscience, and.
James R KrycerFrom the Charles Perkins Centre, School of Molecular Bioscience, and The Garvan Institute of Medical Research, Sydney, New South Wales 2010, Australia, and.
Matthew J PriorThe Garvan Institute of Medical Research, Sydney, New South Wales 2010, Australia, and.
Ben L ParkerFrom the Charles Perkins Centre, School of Molecular Bioscience, and The Garvan Institute of Medical Research, Sydney, New South Wales 2010, Australia, and.
Beverley A MurrowThe Garvan Institute of Medical Research, Sydney, New South Wales 2010, Australia, and.
Jacqueline StöckliFrom the Charles Perkins Centre, School of Molecular Bioscience, and The Garvan Institute of Medical Research, Sydney, New South Wales 2010, Australia, and.
Christopher C MeoliFrom the Charles Perkins Centre, School of Molecular Bioscience, and The Garvan Institute of Medical Research, Sydney, New South Wales 2010, Australia, and.
Geoffrey D Holmanthe Department of Biology and Biochemistry, University of Bath, Bath BA2 7AY, United Kingdom.
David E JamesFrom the Charles Perkins Centre, School of Molecular Bioscience, and The Garvan Institute of Medical Research, Sydney, New South Wales 2010, Australia, and School of Medicine, University of Sydney, Sydney, New South Wales 2006, Australia, david.james@sydney.edu.au.
Garvan Institute of Medical Research · AUUniversity of Sydney · AUUniversity of Bath · GB

Funding

British Heart Foundation PG/11/52/28989Medical Research Council G0300415Medical Research Council G9225018Medical Research Council MR/J003417/1
6 · The paper itself

Abstract

Insulin signaling augments glucose transport by regulating glucose transporter 4 (GLUT4) trafficking from specialized intracellular compartments, termed GLUT4 storage vesicles (GSVs), to the plasma membrane. Proteomic analysis of GSVs by mass spectrometry revealed enrichment of 59 proteins in these vesicles. We measured reduced abundance of 23 of these proteins following insulin stimulation and assigned these as high confidence GSV proteins. These included established GSV proteins such as GLUT4 and insulin-responsive aminopeptidase, as well as six proteins not previously reported to be localized to GSVs. Tumor suppressor candidate 5 (TUSC5) was shown to be a novel GSV protein that underwent a 3.7-fold increase in abundance at the plasma membrane in response to insulin. siRNA-mediated knockdown of TUSC5 decreased insulin-stimulated glucose uptake, although overexpression of TUSC5 had the opposite effect, implicating TUSC5 as a positive regulator of insulin-stimulated glucose transport in adipocytes. Incubation of adipocytes with TNFα caused insulin resistance and a concomitant reduction in TUSC5. Consistent with previous studies, peroxisome proliferator-activated receptor (PPAR) γ agonism reversed TNFα-induced insulin resistance. TUSC5 expression was necessary but insufficient for PPARγ-mediated reversal of insulin resistance. These findings functionally link TUSC5 to GLUT4 trafficking, insulin action, insulin resistance, and PPARγ action in the adipocyte. Further studies are required to establish the exact role of TUSC5 in adipocytes.

Indexed as

Proteomics3T3-L1 CellsAdipocytesAnimalsGlucose Transporter Type 4InsulinMaleMiceRatsRats, WistarTumor Suppressor ProteinsGlucose Transporter Type 4InsulinSlc2a4 protein, ratTrarg1 protein, ratTumor Suppressor Proteinsadipocyteglucose transporter type 4 (GLUT4)insulininsulin resistancemembrane traffickingtumor suppressor candidate 5 (TUSC5)

Identifiers

PMID26240143
PMCPMC4583025
OpenAlexW1080557924

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.